806P Updated toxicity profile and relapse-free survival outcomes using an adapted pyrexia management algorithm in patients with resected stage III BRAF V600E/K-mutant melanoma treated with adjuvant dabrafenib plus trametinib in COMBI-APlus

Autor:	M. Del Vecchio, V.G. Atkinson, B. Ryll, A.M. Menzies, F. Aubin, V. Chiarion Sileni, V. Ferraresi, T. Lesimple, G. Rinaldi, P. Saiag, C. Robert, C. Dutriaux, H.J. Gogas, L. Demidov, A. Gupta, H. Banerjee, S. Sudhir, F. Miranda, M.R. Lau, J.J. Grob
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S914
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0e35468facf281317e0648d28346c709 https://doi.org/10.1016/j.annonc.2022.07.932 Zobrazit plný text záznamu